Ignite Creation Date:
2025-12-24 @ 6:29 PM
Ignite Modification Date:
2026-02-19 @ 10:07 PM
Study NCT ID:
NCT02977468
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2016-11-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer
Sponsor:
Eileen Connolly
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-25
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2016-11-28
First Submit QC Date:
None
Study First Post Date:
2016-11-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-17
Last Update Post Date:
2024-06-20
Last Update Post Date Type:
ACTUAL